Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Asundexian in Patients Following an Acute Myocardial Infarction
NCT04304534Phase 2Completed
- Sponsor
- Bayer
- Start
- Jun 2020
- Primary completion
- Feb 2022
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 2 trial of asundexian in acute myocardial infarction (AMI), sponsored by Bayer. Started Jun 2020; status: completed.
02
Drugs
asundexian
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT04304534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04304534.